Autres langues Cytosorbents Corporation

Actions

CTSO

US23283X2062

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 25/04/2024			Varia. 5j.	Varia. 1 janv.
0,809 ^USD	-1,55 %		+1,00 %	-27,12 %

15/03	Cytosorbents Corporation annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
14/03	Transcript : Cytosorbents Corporation, Q4 2023 Earnings Call, Mar 14, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting	17/04
Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M	14/03
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results	14/03
CytoSorbents to Report Fiscal 2023 Operating and Financial Results	06/03
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference	08/02
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference	08/02
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	31/01
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	23/01
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients	17/01
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients	17/01
Cytosorbents Corporation Reports Excellent Outcomes from A Groundbreaking Randomized Controlled Trial Using Cytosorb® Blood Purification During Heart Transplant, Recently Published in the European Society of Cardiology Journal, Esc Heart Failure	17/01
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	14/01
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	06/01
North American Morning Briefing : Stock Futures Struggle After Weak China Data	02/01
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	29/12
S&P 500 ekes out meager gains, flirts with bull market confirmation	28/12
Sector Update: Health Care Stocks Rise in Late Afternoon	28/12
Top Midday Decliners	28/12
Wall St inches higher as S&P 500 flirts with bull market confirmation	28/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Cytosorbents Corporation

Actions

CTSO

US23283X2062

Autres langues

Filtres